Pfizer third-quarter profit jumps 45 percent

(Reuters) - U.S. drugmaker Pfizer Inc's <PFE.N> third-quarter profit rose nearly 45 percent, driven by lower tax rates and higher sales of breast cancer drug Ibrance and pneumonia vaccine Prevnar.

The company said on Tuesday net income rose to $4.11 billion (3.22 billion pounds) or 69 cents per share in the three months ended Sept. 30, from $2.84 billion or 47 cents per share a year earlier.

Revenue climbed to $13.30 billion from $13.17 billion.

(Reporting by Tamara Mathias in Bengaluru; Editing by Sai Sachin Ravikumar)